PRCT — Procept Biorobotics Cashflow Statement
0.000.00%
Last trade - 00:00- $1.45bn
- $1.22bn
- $308.05m
Annual cashflow statement for Procept Biorobotics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -59.9 | -87.2 | -106 | -91.4 | -95.6 |
| Depreciation | |||||
| Non-Cash Items | 3.9 | 15.4 | 20.2 | 34.3 | 48 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.71 | -11.5 | -26.2 | -47.3 | -7.84 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -57.3 | -80.4 | -108 | -99.2 | -49 |
| Capital Expenditures | -0.592 | -2.65 | -25.2 | -4.41 | -9.36 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.592 | -2.65 | -25.2 | -4.41 | -9.36 |
| Financing Cash Flow Items | — | -4 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 262 | 3.61 | 168 | 180 | 11.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 204 | -79.4 | 34.6 | 76.5 | -47.2 |